148 related articles for article (PubMed ID: 15695324)
1. Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns.
Wang D; Eadala B; Sadilek M; Chamoles NA; Turecek F; Scott CR; Gelb MH
Clin Chem; 2005 May; 51(5):898-900. PubMed ID: 15695324
[No Abstract] [Full Text] [Related]
2. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.
Blanchard S; Sadilek M; Scott CR; Turecek F; Gelb MH
Clin Chem; 2008 Dec; 54(12):2067-70. PubMed ID: 19042989
[TBL] [Abstract][Full Text] [Related]
3. Screening of lysosomal storage disorders: application of the online trapping-and-cleanup liquid chromatography/mass spectrometry method for mucopolysaccharidosis I.
Ombrone D; Malvagia S; Funghini S; Giocaliere E; Della Bona ML; Forni G; De Luca A; Villanelli F; Casetta B; Guerrini R; la Marca G
Eur J Mass Spectrom (Chichester); 2013; 19(6):497-503. PubMed ID: 24378468
[TBL] [Abstract][Full Text] [Related]
4. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis.
Chamoles NA; Blanco M; Gaggioli D
Clin Chem; 2001 Apr; 47(4):780-1. PubMed ID: 11274042
[No Abstract] [Full Text] [Related]
6. A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders.
Gucciardi A; Legnini E; Di Gangi IM; Corbetta C; Tomanin R; Scarpa M; Giordano G
Biomed Chromatogr; 2014 Aug; 28(8):1131-9. PubMed ID: 24449175
[TBL] [Abstract][Full Text] [Related]
7. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).
Duffey TA; Bellamy G; Elliott S; Fox AC; Glass M; Turecek F; Gelb MH; Scott CR
Clin Chem; 2010 Dec; 56(12):1854-61. PubMed ID: 20940330
[TBL] [Abstract][Full Text] [Related]
8. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I.
Polo G; Gueraldi D; Giuliani A; Rubert L; Cazzorla C; Salviati L; Marzollo A; Biffi A; Burlina AP; Burlina AB
Clin Chem Lab Med; 2020 Nov; 58(12):2063-2072. PubMed ID: 32432561
[TBL] [Abstract][Full Text] [Related]
9. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease).
Wang D; Wood T; Sadilek M; Scott CR; Turecek F; Gelb MH
Clin Chem; 2007 Jan; 53(1):137-40. PubMed ID: 17082248
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for lysosomal storage disorders.
Millington DS
Clin Chem; 2005 May; 51(5):808-9. PubMed ID: 15855665
[No Abstract] [Full Text] [Related]
11. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.
Scott CR; Elliott S; Buroker N; Thomas LI; Keutzer J; Glass M; Gelb MH; Turecek F
J Pediatr; 2013 Aug; 163(2):498-503. PubMed ID: 23465405
[TBL] [Abstract][Full Text] [Related]
12. The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
Taylor JL; Clinard K; Powell CM; Rehder C; Young SP; Bali D; Beckloff SE; Gehtland LM; Kemper AR; Lee S; Millington D; Patel HS; Shone SM; Woodell C; Zimmerman SJ; Bailey DB; Muenzer J
J Pediatr; 2019 Aug; 211():193-200.e2. PubMed ID: 31133280
[TBL] [Abstract][Full Text] [Related]
13. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.
Lin SP; Lin HY; Wang TJ; Chang CY; Lin CH; Huang SF; Tsai CC; Liu HL; Keutzer J; Chuang CK
Orphanet J Rare Dis; 2013 Sep; 8():147. PubMed ID: 24053568
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
Johnson BA; Dajnoki A; Bodamer OA
Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
[TBL] [Abstract][Full Text] [Related]
15. Rapid assays for Gaucher and Hurler diseases in dried blood spots using digital microfluidics.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Bali D; Millington DS; Pamula VK
Mol Genet Metab; 2013 Jun; 109(2):218-20. PubMed ID: 23578771
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening of mucopolysaccharidosis type I.
Burlina AB; Gragnaniello V
Crit Rev Clin Lab Sci; 2022 Jun; 59(4):257-277. PubMed ID: 35037566
[TBL] [Abstract][Full Text] [Related]
17. Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.
Spáčil Z; Elliott S; Reeber SL; Gelb MH; Scott CR; Tureček F
Anal Chem; 2011 Jun; 83(12):4822-8. PubMed ID: 21548611
[TBL] [Abstract][Full Text] [Related]
18. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease.
Li Y; Brockmann K; Turecek F; Scott CR; Gelb MH
Clin Chem; 2004 Mar; 50(3):638-40. PubMed ID: 14981030
[No Abstract] [Full Text] [Related]
19. A simple and rapid method based on liquid chromatography-tandem mass spectrometry for the measurement of α-L-iduronidase activity in dried blood spots: an application to mucopolysaccharidosis I (Hurler) screening.
Yang JS; Min HK; Oh HJ; Woo HI; Lee SY; Kim JW; Song J; Park HD
Ann Lab Med; 2015 Jan; 35(1):41-9. PubMed ID: 25553279
[TBL] [Abstract][Full Text] [Related]
20. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
